Krebs Biochemicals & Industries Ltd (KREBSBIO) is currently trading at 60.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Krebs Biochemicals & Industries Ltd specializes in manufacturing Active Pharmaceutical Ingredients using a unique fermentation process. It is among a few globally employing this method. The company is engaged in biotechnology, applying its processes in medicine, agriculture, and industry. This includes contract manufacturing for large multinational companies. Krebs has increased its production capacity from an initial 60 TPA to 150 TPA, demonstrating significant growth since its commercial operations started in 1994. In 2003-04, the company also branched into renewable energy by commissioning a 2.5 MW co-generation power plant in Vizag.

Over the past 52 weeks, Krebs Biochemicals & Industries Ltd has traded between a low of ₹38.52 and a high of ₹81.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Krebs Biochemicals & Industries Ltd has a market capitalization of approximately 120.07. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Krebs Biochemicals & Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -8.52 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 120.07 Cr, Krebs Biochemicals & Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Krebs Biochemicals & Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Krebs Biochemicals & Industries Ltd is -8.52. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.